UK markets open in 6 hours 12 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
145.23-2.49 (-1.69%)
At close: 04:00PM EDT
145.23 0.00 (0.00%)
After hours: 07:59PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-5,968,000
-4,714,000
8,362,000
12,202,000
-747,000
-
Depreciation & amortisation
579,000
621,000
348,000
232,000
31,000
-
Deferred income taxes
1,138,000
828,000
-559,000
-318,000
0
-
Stock-based compensation
331,000
305,000
226,000
142,000
93,000
-
Change in working capital
1,065,000
-139,000
-3,455,000
1,308,000
2,578,000
-
Accounts receivable
976,000
493,000
1,790,000
-1,784,000
-1,385,000
-
Inventory
438,000
747,000
492,000
-1,394,000
-47,000
-
Accounts payable
-173,000
13,000
240,000
204,000
12,000
-
Other working capital
-3,672,000
-3,825,000
4,581,000
13,336,000
1,959,000
-
Other non-cash items
14,000
7,000
28,000
-
62,000
-
Net cash provided by operating activities
-2,882,000
-3,118,000
4,981,000
13,620,000
2,027,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-790,000
-707,000
-400,000
-284,000
-68,000
-
Acquisitions, net
0
-85,000
0
0
-
-
Purchases of investments
-5,196,000
-3,760,000
-11,435,000
-12,652,000
-2,956,000
-
Sales/maturities of investments
8,322,000
8,781,000
6,699,000
4,443,000
1,352,000
-
Other investing activities
-
-23,000
-40,000
-30,000
-
-
Net cash used for investing activities
2,313,000
4,206,000
-5,176,000
-8,523,000
-1,672,000
-
Cash flows from financing activities
Debt repayment
-
-
-
-140,000
-6,215
0
Common stock issued
-
-
0
0
1,853,000
0
Common stock repurchased
-627,000
-1,153,000
-3,329,000
-857,000
0
-
Net cash used provided by (used for) financing activities
-821,000
-1,377,000
-3,448,000
-873,000
2,033,000
-
Net change in cash
-1,390,000
-289,000
-3,643,000
4,224,000
2,388,000
-
Cash at beginning of period
3,461,000
3,217,000
6,860,000
2,636,000
248,000
-
Cash at end of period
2,071,000
2,928,000
3,217,000
6,860,000
2,636,000
-
Free cash flow
Operating cash flow
-2,882,000
-3,118,000
4,981,000
13,620,000
2,027,000
-
Capital expenditure
-790,000
-707,000
-400,000
-284,000
-68,000
-
Free cash flow
-3,672,000
-3,825,000
4,581,000
13,336,000
1,959,000
-